4-Hydroxy Penbutolol D9

4-Hydroxy Penbutolol D9 is a deuterated form of 4-Hydroxy Penbutolol, which is a beta-blocker drug used to treat high blood pressure and other cardiovascular conditions. The deuterated form contains nine atoms of deuterium, a stable isotope of hydrogen, and is commonly used in research studies to trace the metabolism and pharmacokinetics of the drug. Chemically, 4-Hydroxy Penbutolol D9 is a selective beta-1 adrenergic receptor antagonist, which means it blocks the effects of adrenaline and noradrenaline on the heart and blood vessels. This leads to a decrease in heart rate and blood pressure, which can be beneficial for patients with hypertension or heart failure. The usage of 4-Hydroxy Penbutolol D9 is primarily limited to research purposes, where it is used as a tracer to investigate the pharmacokinetics of the parent drug. It is also used in drug metabolism studies to determine how the drug is metabolized in the body, and to identify any potential drug-drug interactions that may occur. In conclusion, 4-Hydroxy Penbutolol D9 is a useful tool in the field of pharmacology and drug development, as it allows researchers to gain a better understanding of the pharmacokinetics and metabolism of the drug. Its selective beta-blocker properties make it a promising therapeutic option for cardiovascular conditions, but further research is needed to determine its clinical efficacy and safety.